The Boston Globe @BostonGlobe · 03 Sep 2026
If regulators approve Moderna and Merck's personalized cancer vaccine, the treatment will be a triumph of immunology and cancer biology. But it may also be a triumph of the algorithm. https://t.co/UxQWyvsr4c
1 524Views
2Likes
0Reposts
0Replies
0Quotes
0Bookmarks
Is that a lot?
0.58×vs this author's median2 609 views is typical
33Percentile for this authorof 9 recent posts
0.07×vs 100K–1M median22 159 views is typical
0.20%Reachviews ÷ followers
0.13%Engagement rateof viewers reacted